View in EDS HTML Full Text PDF Full Text

Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients.

Saved in:
Bibliographic Details
Title: Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients.
Authors: Cárdenas, Graciela1 (AUTHOR), Chávez-Canales, María2 (AUTHOR), Espinosa, Ana María3 (AUTHOR), Jordán-Ríos, Antonio4 (AUTHOR), Malagon, Daniel Anica3 (AUTHOR), Murillo, Manlio Fabio Márquez4 (AUTHOR), Araujo, Laura Victoria Torres4 (AUTHOR), Campos, Ricardo Leopoldo Barajas4 (AUTHOR), Wong-Chew, Rosa María5 (AUTHOR), González, Luis Esteban Ramirez6 (AUTHOR), Cresencio, Karent Ibet6 (AUTHOR), Velázquez, Enrique García6 (AUTHOR), de la Cerda, Mariana Rodriguez6 (AUTHOR), Leyva, Yoana4 (AUTHOR), Hernández-Ruiz, Joselin3 (AUTHOR), Hernández-Medel, María Luisa3 (AUTHOR), León-Hernández, Mireya3 (AUTHOR), Quero, Karen Medina7 (AUTHOR), Monciváis, Anahí Sánchez7 (AUTHOR), Díaz, Sergio Hernández7 (AUTHOR)
Source: Trials. 2/14/2022, Vol. 23 Issue 1, p1-11. 11p. 1 Color Photograph, 1 Diagram, 1 Chart.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17456215
DOI:10.1186/s13063-022-06075-5